By contrast, ZNF154 displayed the largest amount of differential methylation for stomach cancer (difference in median methylation 0.63), improving performance over TLX1 or GALR1 (difference in median beta value at 0.50 and 0.30, respectively). This evidence concerns the gene ZNF154 and gastric neoplasm.